RBCs |
Provide markers of self, neutralizing pore-forming toxins |
Platelets |
53, 55, 62 |
Cancer cells |
54, 66 |
Platelets |
Provide markers of self |
RBCs |
53 |
Cancer stem cells |
67 |
Offer ligands for targeting circulating tumor cells (CTCs) |
Leukocytes |
58 |
Neutrophils |
63 |
Leukocytes |
Confer homologous features to reduce the unintended cell-binding interactions |
Platelets |
58 |
Macrophages |
Provide markers of self |
Cancer cells |
65 |
Confer homologous features to reduce the unintended cell-binding interactions |
Cancer cells |
68 |
Neutrophils |
Offer ligands for targeting CTCs |
Platelets |
63 |
Dendritic cells (DCs) |
Provide immunological co-stimulatory molecules and lymph node-targeting |
Cancer cells |
56, 57 |
Cancer cells/Cancer stem cells |
Offer homotypic targeting to tumors and CTCs |
RBCs |
54 |
Macrophages |
65, 68 |
Dendritic cells |
56, 57 |
Platelets |
67 |
Bacterium (Salmonella) |
Serve as an immunological adjuvant to induce DC maturation |
Cancer cells |
69 |